Viewing Study NCT06508567



Ignite Creation Date: 2024-10-26 @ 3:35 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06508567
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-03-15

Brief Title: Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era
Sponsor: None
Organization: None

Study Overview

Official Title: Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SHAPE-PSMA
Brief Summary: This is an interventional single-centre single-arm non-randomized prospective feasibility trial investigating salvage MR-guided High-Dose-Rate brachytherapy for prostate bed recurrence after postoperative radiotherapy
Detailed Description: Patients who received previous adjuvant or salvage radiotherapy to the prostate bed

Isolated prostate bed recurrence based on PSMA PET biopsy-proven and MR visible

Baseline QoLs questionnaires PSA pelvic magnetic resonance imaging MRI scan for RT planning

Two fractions of 13 Gy each delivered over 7-21 days GTVHDR delineation based on MRI-guided and PSMA PET biopsy data as applicable

Follow-Up after treatment 60 months PSA CTCAE v50 MRI pelvis - PSMA-PET scan optional at 24 months

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None